Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease

Author(s):: Coenen, M.J.H.; Jong, D.J. de; Marrewijk, C.J. van; Derijks, L.J.J.; Vermeulen, S.H.; Wong, D.R.; Klungel, O.H.; Verbeek, A.L.M.; Hooymans, P.M.; Peters, W.H.M.; Morsche, R.H.M. te; Newman, W.G.; Scheffer, H.; Guchelaar, H.J. (0000-0002-7085-1383); Franke, B.

Published: 2015
Publication type: Article / Letter to editor

LeukocyteAdverse EventPharmacogeneticSide Effect

Date issued: 2015-10-31
Language: English
Is part of
hdl: 1887/117546
doi: 10.1053/j.gastro.2015.06.002